Sign Up to like & get
recommendations!
0
Published in 2024 at "eLife"
DOI: 10.1101/2023.10.24.563834
Abstract: Blocking inhibitory receptors like PD-1 and CTLA-4 has revolutionized cancer treatment in recent years. However, despite major successes in melanoma and lung cancer, the majority of cancer types are not responsive to these immunotherapies. As…
read more here.
Keywords:
inhibitory receptors;
pipeline;
novel inhibitory;
immune inhibitory ... See more keywords